Literature DB >> 23091430

Putting oncology patients at risk.

Bob Carlson.   

Abstract

Using genomic tests to personalize oncology treatment is a worthy endeavor. But when the rush to capitalize on biomedical research overcomes the rules of evidence, it's the patients who suffer.

Entities:  

Year:  2012        PMID： 23091430      PMCID： PMC3474449     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  3 in total

1.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

2.  Genomic signatures to guide the use of chemotherapeutics.

Authors:  Anil Potti; Holly K Dressman; Andrea Bild; Richard F Riedel; Gina Chan; Robyn Sayer; Janiel Cragun; Hope Cottrill; Michael J Kelley; Rebecca Petersen; David Harpole; Jeffrey Marks; Andrew Berchuck; Geoffrey S Ginsburg; Phillip Febbo; Johnathan Lancaster; Joseph R Nevins
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

3.  Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.

Authors:  David S Hsu; Bala S Balakumaran; Chaitanya R Acharya; Vanja Vlahovic; Kelli S Walters; Katherine Garman; Carey Anders; Richard F Riedel; Johnathan Lancaster; David Harpole; Holly K Dressman; Joseph R Nevins; Phillip G Febbo; Anil Potti
Journal:  J Clin Oncol       Date:  2007-10-01       Impact factor: 44.544
  3 in total
  1 in total

1.  Transparency and reproducibility in artificial intelligence.

Authors:  Benjamin Haibe-Kains; George Alexandru Adam; Ahmed Hosny; Farnoosh Khodakarami; Levi Waldron; Bo Wang; Chris McIntosh; Anna Goldenberg; Anshul Kundaje; Casey S Greene; Tamara Broderick; Michael M Hoffman; Jeffrey T Leek; Keegan Korthauer; Wolfgang Huber; Alvis Brazma; Joelle Pineau; Robert Tibshirani; Trevor Hastie; John P A Ioannidis; John Quackenbush; Hugo J W L Aerts
Journal:  Nature       Date:  2020-10-14       Impact factor: 69.504
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.